Lasa Supergenerics Limited

25.75

INR
-0.53(-2.02%)
As of November 14, 2024 10:00:00 AM

Lasa Supergenerics Limited Share Price Information

24 hour Low and High

Low: 25.75
High: 26.28

All time High

93.92

Price Change 1h

+₹-0.53 +-2.02%

Price Change 1d

+₹-0.53 +-2.02%

Price Change 1w

+₹-1.64 +-5.99%

Lasa Supergenerics Limited Market Information

Exchange

NSE

Market Cap

131.05 Cr

About Lasa Supergenerics Limited Share

Lasa Supergenerics Limited engages in the research, manufacture, and marketing of animal and human healthcare products in India. It offers API products comprising fenbendazole, toldimphos sodium, cyromazine, albendazole, ricobendazole, oxfendazole, closantel base, closantel sodium dihydrate BP, nitroxynil, rafoxanide, oxyclozanide, ornidazole, and halquinol, as well as 2,6-diiodo-4-nitrophenol; and other API products. The company also provides animal feed ingredients, including calcium iodate; and reagents for therapeutic use, such as potassium iodide. In addition, it exports its products. Lasa Supergenerics Limited was incorporated in 2016 and is based in Ratnagiri, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

77

CEO

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Lasa Supergenerics Limited Announces Successful withdrawal of Application under Section 7 of I&B, 2016 Filed Against the Company by Financial Creditor
  • Lasa Supergenerics Ltd. Secures Financial Future with Creditor Settlement
  • Lasa Supergenerics Q4 Results Live : loss rise by 1.92% YOY | Company Business News
  • There's No Escaping Lasa Supergenerics Limited's (NSE:LASA) Muted Revenues
  • Lasa Supergenerics Stock Hits 52-Week Low, Given 'Strong Sell' Rating by MarketsMOJO

FAQs

Lasa Supergenerics Limited

25.75

INR
-0.53(-2.02%)
As of November 14, 2024 10:00:00 AM

Lasa Supergenerics Limited Share Price Information

24 hour Low and High

Low: 25.75
High: 26.28

All time High

93.92

Price Change 1h

+₹-0.53 +-2.02%

Price Change 1d

+₹-0.53 +-2.02%

Price Change 1w

+₹-1.64 +-5.99%

Lasa Supergenerics Limited Market Information

Exchange

NSE

Market Cap

131.05 Cr

About Lasa Supergenerics Limited Share

Lasa Supergenerics Limited engages in the research, manufacture, and marketing of animal and human healthcare products in India. It offers API products comprising fenbendazole, toldimphos sodium, cyromazine, albendazole, ricobendazole, oxfendazole, closantel base, closantel sodium dihydrate BP, nitroxynil, rafoxanide, oxyclozanide, ornidazole, and halquinol, as well as 2,6-diiodo-4-nitrophenol; and other API products. The company also provides animal feed ingredients, including calcium iodate; and reagents for therapeutic use, such as potassium iodide. In addition, it exports its products. Lasa Supergenerics Limited was incorporated in 2016 and is based in Ratnagiri, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

77

CEO

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Lasa Supergenerics Limited Announces Successful withdrawal of Application under Section 7 of I&B, 2016 Filed Against the Company by Financial Creditor
  • Lasa Supergenerics Ltd. Secures Financial Future with Creditor Settlement
  • Lasa Supergenerics Q4 Results Live : loss rise by 1.92% YOY | Company Business News
  • There's No Escaping Lasa Supergenerics Limited's (NSE:LASA) Muted Revenues
  • Lasa Supergenerics Stock Hits 52-Week Low, Given 'Strong Sell' Rating by MarketsMOJO

FAQs